ro 5-3335 has been researched along with zidovudine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holly, M; Hsu, MC; Potash, MJ; Richman, DD; Schutt, AD; Sherman, MI; Slice, LW; Volsky, DJ | 2 |
2 other study(ies) available for ro 5-3335 and zidovudine
| Article | Year |
|---|---|
Discovery and characterization of an HIV-1 Tat antagonist.
Topics: Animals; Antiviral Agents; Benzodiazepinones; CHO Cells; Cricetinae; Gene Deletion; Gene Expression; Gene Products, tat; Genes, tat; HIV Long Terminal Repeat; HIV-1; HIV-2; Kinetics; Promoter Regions, Genetic; Pyrroles; tat Gene Products, Human Immunodeficiency Virus; Virus Replication; Zidovudine | 1992 |
Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist.
Topics: Antiviral Agents; Benzodiazepinones; Cell Line; Gene Products, tat; HIV Long Terminal Repeat; HIV-1; HIV-2; Humans; Kinetics; Promoter Regions, Genetic; Pyrroles; tat Gene Products, Human Immunodeficiency Virus; Virus Replication; Zidovudine | 1991 |